BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1260863)

  • 1. Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.
    Audibert F; Chédid L; Lefrancier P; Choay J
    Cell Immunol; 1976 Feb; 21(2):243-9. PubMed ID: 1260863
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls.
    Chedid L; Parant M; Parant F; Gustafson RH; Berger FM
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):855-8. PubMed ID: 4337242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative relationship for adjuvanticity between antigen and adjuvant.
    Tanaka A; Anaka K; Hagimoto D; Sugiyama K
    Int Arch Allergy Appl Immunol; 1967; 32(2):224-35. PubMed ID: 4965711
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterial substitutes in "complete" Freund's adjuvant. Effect on antibody production and delayed hypersensitivity to bovine serum albumin.
    Salvaggio JE; Castro-Murillo E
    J Immunol; 1968 Jun; 100(6):1340-52. PubMed ID: 4972188
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a water-soluble adjuvant fraction from "Mycobacterium smegmatis" with sperm extract to induce autoimmune aspermatogenic orchiepididymitis in guniea pigs (author's transl)].
    Toullet F; Audibert F; Chedid L; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):901-10. PubMed ID: 4282838
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.
    Adam A; Ciorbaru R; Petit JF; Lederer E
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):851-4. PubMed ID: 4502937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvanticity and strains of mycobacteria.
    Hiu IJ
    Jpn J Exp Med; 1980 Jun; 50(3):183-8. PubMed ID: 7001095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant.
    Tanaka A
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvant.
    Audibert F; Chedid L
    Infect Immun; 1976 Dec; 14(6):1263-8. PubMed ID: 1002297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of adjuvants on the immunological response of the chicken. I. Effects on primary and secondary responses of various adjuvants in the primary stimulus.
    Steinberg SV; Munro JA; Fleming WA; French VI; Stark JM; White RG
    Immunology; 1970 May; 18(5):635-44. PubMed ID: 4986929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically defined bacterial products with immunopotentiating activity.
    Chedid L; Audibert F
    J Infect Dis; 1977 Aug; 136 Suppl():S246-51. PubMed ID: 330778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of Freund's complete and incomplete adjuvants. Relation of adjuvanticity to structure.
    Dvorak AM; Dvorak HF
    Immunology; 1974 Jul; 27(1):99-114. PubMed ID: 4605156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mycobacterial water-soluble adjuvant (MAF3) on the immune response of guinea pigs to the hapten-carrier conjugates.
    Kumazawa Y; Shibusawa A; Mizunoe K; Nakano M; Yasuhira K
    Microbiol Immunol; 1978; 22(10):655-9. PubMed ID: 105230
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of water-soluble adjuvant (WSA) on New Zealand (NZB X NZW) F1 hybrid mice.
    Abe C; Chia D; Barnett EV; Pearson CM; Shiokawa Y
    Clin Immunol Immunopathol; 1977 Jul; 8(1):17-27. PubMed ID: 880745
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvanticity of mycobacterial cell walls.
    Azuma I; Kishimoto S; Yamamura Y; Petit JF
    Jpn J Microbiol; 1971 Mar; 15(2):193-7. PubMed ID: 4930810
    [No Abstract]   [Full Text] [Related]  

  • 16. Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives.
    Merser C; Sinay P; Adam A
    Biochem Biophys Res Commun; 1975 Oct; 66(4):1316-22. PubMed ID: 1191296
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation, characterization, and biological properties of a tuberculin-active peptidoglycan isolated from the culture filtrate of Mycobacterium tuberculosis.
    Gupta KC; Landi S
    Infect Immun; 1980 Feb; 27(2):344-50. PubMed ID: 6769799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits.
    Johnston BA; Eisen H; Fry D
    Lab Anim Sci; 1991 Jan; 41(1):15-21. PubMed ID: 1849580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response.
    Nauciel C; Fleck J; Martin JP; Mock M; Nguyen-Huy H
    Eur J Immunol; 1974 May; 4(5):352-6. PubMed ID: 4604064
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant and immunostimulating activities of water-soluble substances extracted from Mycobacterium tuberculosis (var. hominis).
    Werner GH; Maral R; Floch F; Migliore-Samour D; Jollès P
    Biomedicine; 1975 Sep; 22(5):440-52. PubMed ID: 4166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.